Article Information
History
- August 2, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Manuel Pino-González1,#,
- Martín Lázaro-Quintela1,2,#,
- Irene Alonso-Álvarez1,
- María Gallardo-Gómez1,
- Laura Juaneda-Magdalena1,
- Alejandro Francisco-Fernández3,
- Silvia Calabuig-Fariñas4,5,6,
- Eloisa Jantus-Lewintre5,6,7 and
- Mónica Martínez-Fernández1,*
- 1Translational Oncology Group. Galicia Sur Health Research Institute (IIS Galicia Sur). SERGAS UVIGO. Hospital Álvaro Cunqueiro. Carretera Clara Campoamor, 341. 36213 (Vigo), Spain
- 2Medical Oncology Service. Hospital Álvaro Cunqueiro. Carretera Clara Campoamor, 341. 36213 (Vigo), Spain
- 3Medical Oncology Service. Hospital Provincial de Pontevedra. Calle Doutor Loureiro Crespo, 2. 36001 (Pontevedra), Spain
- 4Department of Pathology. Universitat de València, 46010 (Valencia), Spain
- 5Centro de Investigación Biomédica en Red Cáncer (CIBERONC). Valencia, Spain
- 6Mixed Unit TRIAL. General University Hospital of Valencia Research Foundation and Príncipe Felipe Research Center. Hospital General Universitario de Valencia, 46014 (Valencia), Spain
- 7Department of Biotechnology. Universitat Politècnica de València, 46022 (Valencia), Spain
- ↵*Corresponding author: Mónica Martínez-Fernández. Translational Oncology Group. Galicia Sur Health Research Institute (IIS Galicia Sur). SERGAS-UVIGO. Hospital Álvaro Cunqueiro. Estrada de Clara Campoamor, 341, 36213 (Vigo), Spain., Email: monica.martinez{at}iisgaliciasur.es
↵# Equal contribution
Posted August 02, 2024.
Tissue and Peripheral T-cell Repertoire Predicts Immunotherapy Response and Progression-Free Survival in NSCLC Patients
